tiprankstipranks

John Deford Insider Profile

4 Followers
John Deford, Sr. VP Sci Tech and Clin Afrs at CR Bard, holds 0.00 shares in CR Bard (Ticker: BCR), holds ― shares in NuVasive (Ticker: NUVA), holds 70.05K shares in Maravai Lifesciences Holdings (Ticker: MRVI).
tipranks
John Deford

John Deford
CR Bard (BCR)
Sr. VP Sci Tech and Clin Afrs

Ranked #68,711 out of 99,335 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-23.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
46.44%
41.96%
11.60%
A breakdown of John Deford's holdings

Insider Roles

Globus Medical
(GMED)
Director
Nordson
(NDSN)
Director
Maravai Lifesciences Holdings
(MRVI)
Director
Roles that John Deford holds in companies

Most Profitable Insider Trade

Stock:
CR Bard
(BCR)
Rating:Informative Sell
Date:Aug 06, 2015 - Aug 06, 2016
Return:-12.30%
The most profitable trade made by John Deford

John Deford's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BCR
CR Bard
Jan 03, 2018
Uninformative Buy
$0.00
NUVA
NuVasive
Nordson
Nov 04, 2024
Director
Uninformative Buy
186.03K
$1.17M
Maravai Lifesciences Holdings
Nov 14, 2024
Director
Informative Buy
100.63K
$324.31K
Globus Medical
Sep 06, 2023
Director
Uninformative Buy
$1.30M
List of latest transactions for each holding click on a transaction to see John Deford's performance on stock

John Deford insider profile FAQ

What is the percentage of profitable transactions made by John Deford?
The percentage of profitable transactions made by John Deford is 0%.
    What is the average return per transaction made by John Deford?
    The average return per transaction made by John Deford is -23.50%.
      What stocks does John Deford hold?
      John Deford holds: BCR, NUVA, NDSN, MRVI, GMED stocks.
        What was John Deford’s latest transaction?
        John Deford latest transaction was an Uninformative Buy of ―.
          What was John Deford's most profitable transaction?
          John Deford’s most profitable transaction was an Informative Sell of BCR stock on August 6, 2015. The return on the trade was -12.30%.
            What is John Deford's role in CR Bard?
            John Deford's role in CR Bard is Sr. VP Sci Tech and Clin Afrs.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.